Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Disciplined Investing, especially the NAIC way -- Ignore unavailable to you. Want to Upgrade?

To: Steven Dopp who wrote (335)	6/26/2002 1:01:50 PM
From: - with a K	Read Replies (2) \| Respond to of 469

I proposed it in one of my clubs a while back but there was no support. I've done it for my personal portfolio, and know that there are two schools of thought on using this tactic. I'd like to say that I've successfully and consistently used it near tops of a run or recovery, but that would be stretching the truth too much! But that would be the ideal time, IMO. For example, a long time ago I bought ORCL after it fell hard on what I believe was excessive overreaction. I watched it slowly gain 40% or so, feeling proud of my pick. That's when I should have used a stop, but I didn't, and now I feel it's too late to sell. - Kris

To: Steven Dopp who wrote (335)	7/2/2002 1:16:31 AM
From: The Philosopher	Read Replies (1) \| Respond to of 469

We haven't, and I doubt we would do it on more than one or at most two stocks at a time. As long as the fundamentals remain strong, I usually look at those dips as buying, not selling, opportunities. But it depends on the stocks you're in, and the confidence you have in their long term growth potential.

To: Steven Dopp who wrote (335)	7/2/2002 2:32:47 PM
From: - with a K	Read Replies (1) \| Respond to of 469

Looks like a great move to stop out of Elan with today's news. Wow, what a drop. Any case to get in at $1.95? - Kris DUBLIN, July 2 (Reuters) - Elan Corp (Irish:ELN.I - News; NYSE:ELN - News), the Irish drugmaker whose shares have crashed on accounting worries, said on Tuesday its business recovery plan and a drop in the value of its investments would result in "significant" charges. The news sent its punch-drunk shares even lower, halving the value of the company on the Irish Stock Exchange. The company also said it had sold certain royalty rights on some of its products -- effectively giving up some future revenue for cash -- but firmly rejected suggestions it was facing a liquidity crisis in servicing its debt. "There is a misperception out there that the company has a liquidity crisis, which is simply not the case," Chairman and Chief Executive Donal Geaney told Reuters. "The company has...substantially more cash than the sum of all its obligations over the next two years, so we have more than enough cash to meet our requirements." In a statement accompanying the firm's 2001 annual report for the U.S. Securities and Exchange Commission, Geaney said Elan faced "the most challenging time it its corporate history". 90-PERCENT CLUB Elan's stock has been beaten down more than 90 percent from 52-week peaks amid a global controversy over corporate accounting that has engulfed giants like Enron, WorldCom and Xerox. (snip)